145 related articles for article (PubMed ID: 34242856)
1. Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment.
Paskulin LD; Starosta RT; Bertholdo D; Vairo FP; Vedolin L; Schwartz IVD
Blood Cells Mol Dis; 2021 Sep; 90():102591. PubMed ID: 34242856
[TBL] [Abstract][Full Text] [Related]
2. Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-year follow-up.
Elstein D; Haims AH; Zahrieh D; Cohn GM; Zimran A
Blood Cells Mol Dis; 2014; 53(1-2):56-60. PubMed ID: 24581483
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
Laudemann K; Moos L; Mengel E; Lollert A; Hoffmann C; Brixius-Huth M; Wagner D; Düber C; Staatz G
Blood Cells Mol Dis; 2016 Mar; 57():35-41. PubMed ID: 26852653
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
Fedida B; Touraine S; Stirnemann J; Belmatoug N; Laredo JD; Petrover D
Eur Radiol; 2015 Oct; 25(10):2969-75. PubMed ID: 25875285
[TBL] [Abstract][Full Text] [Related]
5. Semiquantitative assessment of skeletal response to enzyme replacement therapy for Gaucher's disease using the bone marrow burden score.
Robertson PL; Maas M; Goldblatt J
AJR Am J Roentgenol; 2007 Jun; 188(6):1521-8. PubMed ID: 17515371
[TBL] [Abstract][Full Text] [Related]
6. Retrospective Analysis of Whole-Body Magnetic Resonance Imaging of Bone Manifestations in Long-Term Treated Patients with Gaucher Disease Type 1.
Lollert A; Laudemann K; Mengel E; Hoffmann C; Moos L; Reinke J; Brixius-Huth M; Hennermann JB; Düber C; Staatz G
Klin Padiatr; 2019 Mar; 231(2):52-59. PubMed ID: 30481833
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
Laudemann K; Moos L; Mengel KE; Lollert A; Reinke J; Brixius-Huth M; Wagner D; Düber C; Staatz G
Rofo; 2015 Dec; 187(12):1093-8. PubMed ID: 26200566
[TBL] [Abstract][Full Text] [Related]
8. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
Degnan AJ; Ho-Fung VM; Wang DJ; Ficicioglu C; Jaramillo D
Clin Imaging; 2020 Jul; 63():1-6. PubMed ID: 32120306
[TBL] [Abstract][Full Text] [Related]
9. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
Tóth J; Szücs FZ; Benkö K; Maródi L
Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
[TBL] [Abstract][Full Text] [Related]
10. [Gaucher disease: MR evaluation of bone marrow features during treatment with enzyme replacement].
Poll LW; vom Dahl S; Koch JA; Börner D; Willers R; Cohnen M; Jung G; Scherer A; Niederau C; Häussinger D; Mödder U
Rofo; 2001 Oct; 173(10):931-7. PubMed ID: 11588682
[TBL] [Abstract][Full Text] [Related]
11. Fat fraction quantification of bone marrow in the lumbar spine using the LiverLab assessment tool in healthy adult volunteers and patients with Gaucher disease.
Gan C; Robertson PL; Lai JKC; Szer J
Intern Med J; 2023 Jul; 53(7):1163-1169. PubMed ID: 35762150
[TBL] [Abstract][Full Text] [Related]
12. Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging--initial experience.
Maas M; van Kuijk C; Stoker J; Hollak CE; Akkerman EM; Aerts JF; den Heeten GJ
Radiology; 2003 Nov; 229(2):554-61. PubMed ID: 14526090
[TBL] [Abstract][Full Text] [Related]
13. Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease.
van Dussen L; Zimran A; Akkerman EM; Aerts JM; Petakov M; Elstein D; Rosenbaum H; Aviezer D; Brill-Almon E; Chertkoff R; Maas M; Hollak CE
Blood Cells Mol Dis; 2013 Mar; 50(3):206-11. PubMed ID: 23199589
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
Poll LW; Koch JA; vom Dahl S; Willers R; Scherer A; Boerner D; Niederau C; Häussinger D; Mödder U
Skeletal Radiol; 2001 Sep; 30(9):496-503. PubMed ID: 11587517
[TBL] [Abstract][Full Text] [Related]
15. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
Mariani G; Filocamo M; Giona F; Villa G; Amendola A; Erba P; Buffoni F; Copello F; Pierini A; Minichilli F; Gatti R; Brady RO
J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
[TBL] [Abstract][Full Text] [Related]
16. Use of IDEAL-IQ in Quantifying Femoral Bone Marrow Involvement in Gaucher Disease.
Hou B; Cidanwangjiu ; Zhang H; Wang F; Qiu Z; Zhang Y; Jin Z
J Comput Assist Tomogr; 2023 Jul-Aug 01; 47(4):637-642. PubMed ID: 37382507
[TBL] [Abstract][Full Text] [Related]
17. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
[TBL] [Abstract][Full Text] [Related]
18. S-MRI score: A simple method for assessing bone marrow involvement in Gaucher disease.
Roca M; Mota J; Alfonso P; Pocoví M; Giraldo P
Eur J Radiol; 2007 Apr; 62(1):132-7. PubMed ID: 17161930
[TBL] [Abstract][Full Text] [Related]
19. Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase.
Rosenthal DI; Doppelt SH; Mankin HJ; Dambrosia JM; Xavier RJ; McKusick KA; Rosen BR; Baker J; Niklason LT; Hill SC
Pediatrics; 1995 Oct; 96(4 Pt 1):629-37. PubMed ID: 7567322
[TBL] [Abstract][Full Text] [Related]
20. Enhanced vertebra to disk ratio as a new semi-quantitative imaging biomarker for Gaucher disease patients.
Beaumont H; Maas M; Wormanns D; Zaim S; Klifa C; Faye N; Iannessi A
Eur J Radiol; 2020 Aug; 129():109091. PubMed ID: 32497944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
